Organigram Global Q2 Earnings Call Highlights

2 hours ago 5

MarketBeat

Tue, May 12, 2026 astatine 8:07 AM CDT 9 min read

Organigram Global logo

Key Points

Interested successful Organigram Global Inc.? Here are 5 stocks we similar better.
Organigram Global posted weaker fiscal Q2 2026 results, with nett gross down astir 9% twelvemonth implicit twelvemonth to CAD 59.8 cardinal and adjusted EBITDA falling to CAD 0.9 million. Management blamed operational issues successful vapes and infused pre-rolls, softer Canadian marketplace growth, and planetary angiosperm spec challenges.
The institution said it is taking corrective action, including tighter prime controls for infused pre-rolls and a merchandise refresh successful vapes, wherever stock fell arsenic user request shifted toward higher-potency formats. Despite those setbacks, Organigram said flower, edibles, beverages and concentrates showed spot and it remained Canada’s No. 1 licensed shaper by marketplace share.
Organigram expects the precocious completed Sanity Group acquisition to boost planetary growth, particularly successful Germany, and raised fiscal 2026 guidance to nett gross supra CAD 350 cardinal with adjusted EBITDA and adjusted gross borderline supra fiscal 2025 levels. The institution besides reported improved currency travel and said it inactive has astir CAD 40 cardinal of disposable liquidity aft financing.

Three Reasons It’s Time To Get Bullish On Organigram

Organigram Global (NASDAQ:OGI) reported a weaker 2nd 4th for fiscal 2026, with absorption attributing the diminution to operational issues successful cardinal merchandise categories, softer Canadian cannabis marketplace maturation and continued challenges with planetary angiosperm specifications.

Chief Executive Officer James Yamanaka, who joined the institution astir 4 months ago, said the 4th was “challenging” but emphasized that Organigram has identified the issues affecting show and is taking corrective steps. He said the institution remains focused connected execution, improving underperforming areas and integrating the precocious acquired Sanity Group opening successful the 3rd quarter.

→ Beyond NVIDIA: Picks-and-Shovels AI Plays with Strong Momentum

OrganiGram’s Turnaround Begins To Blossom

Net gross for the 4th was CAD 59.8 million, down from CAD 65.6 cardinal successful the prior-year period, a diminution of astir 9%. Chief Financial Officer Greg Guyatt said the alteration was chiefly driven by marketplace stock erosion successful vapes and infused pre-rolls, partially offset by spot successful different parts of the portfolio.

Operational Issues Weighed connected Vapes and Infused Pre-Rolls

Yamanaka said Organigram’s infused pre-roll concern was affected by prime inconsistencies aft the institution internalized pre-roll accumulation astatine its Aylmer facility. He said the transition, which included the usage of caller accumulation equipment, introduced higher variability successful capable rates and little merchandise consistency arsenic processes were calibrated.

Read Entire Article